Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Jinkushal Industries Limited Announces Unaudited Financial Results for the Quarter and Nine Months Ended December 31, 2025 Business
  • Consumer Privacy Has Entered the Premium Tier Technology
  • Employee Wellness: From Buzzword to Boardroom Necessity Business
  • Brahmasri Madugula Nagaphani Sarma Honored with Padma Shri for reviving the art of Avadhanam Lifestyle
  • Living With AI: The New Human Lifestyle in 2026 Lifestyle
  • Vasu Healthcare forays in Exclusive Branded Outlets with ‘Vasu Naturals’ to strengthen Direct Consumer Connect Business
  • What You Need to Know About Term Insurance Claims Finance
  • Sri Baddam Karunakar Reddy Inaugurates IDL Explosives’ 9,000 MT Bolkunda Silo Unit at Asansol Business

Remedium Lifecare Announces INR 49.19 Cr Rights Issue for Expansion

Posted on April 9, 2025 By

Mumbai (Maharashtra) [India], April 9: Remedium Lifecare Limited (BSE: 539561),a fast-growing manufacturer of pharmaceutical intermediates and specialty chemicals, is pleased to announce that it has received approval from the Bombay Stock Exchange (BSE) for its proposed rights issue.

The approval paves the way for the company to raise growth capital from its existing shareholders, further strengthening its financial foundation and supporting its strategic initiatives, including manufacturing expansion, product development, and global market penetration.

Key Highlights of the Rights Issue (as approved):

  • Record Date: Tuesday, April 15, 2025
  • Issue Size: ₹4,919.04 Lakhs (Assuming Full Subscription)
  • Price per Share: ₹1.00 per Equity Share
  • Total Number of Shares: 49,19,04,000 fully paid-up equity shares of face value ₹1/- each
  • Rights Ratio: 61 Rights Equity Shares for every 50 fully paid-up equity shares held as on the Record Date
  • Instrument: Fully paid-up equity shares having a face value of ₹1/- each
  • Purpose: Working capital Requirements, Equipment for R&D and expansion

“This approval from the BSE marks a significant milestone in our journey. We remain committed to enhancing shareholder value while scaling up our operations responsibly and sustainably,” said Adarsh Munjal , Whole Time Director, Remedium Lifecare Ltd.

The rights issue comes at a time when Remedium Lifecare is gaining strong traction in international markets. In February 2025, the company secured a multi-year export contract worth ₹182.7 crore with a leading UK-based pharmaceutical distributor. The company is well- positioned to capitalize on rising global demand in key therapeutic segments such as anti- infectives, cardiovascular, CNS, and oncology-supportive drugs.

About Remedium Lifecare:

Founded in 1988, Remedium Lifecare Ltd. is a BSE-listed pharmaceutical company engaged in the supply of Active Pharmaceutical Ingredient (API) intermediates and specialty chemicals. With an emphasis on quality, compliance, and global reach, the company continues to expand its presence while playing a pivotal role in India’s pharmaceutical ecosystem.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: VVIP Infratech Limited Secures Rs. 414 Crores in Government-Funded Infrastructure Projects
Next Post: Tech Behind Atharv Lifestyle’s Timely Delivery: Promise, Precision and Premium Living

Related Posts

  • Khimji Group’s Engineering Business Targets Next Phase of Growth, Eyes Rs 400 Crore Milestone Amid Rising Industrial Demand Business
  • 17-year-old Ahmedabad girl Meha Parekh is helping women become insured Business
  • Manaksia Coated Metals & Industries Undertakes Upgradation, Capacity Expansion for its Continuous Galvanizing Line Business
  • Jainam Broking Limited Unveils IOC 4.0, the Largest Options Trading Community Gathering in India Business
  • Dudani Retail’s IPO to Open on September 25, 2026; Company Aims to Raise Rs. 10.54 Crore Business
  • Top 5 AI Platforms to upskill your career Business

Recent Posts

  • ‘Mere Mahavir 3.1 – Mahavir Nirvana Katha’ Concludes on a Grand Spiritual Note at Bharat Mandapam
  • Kingston Debuts at Embedded World India, Deepening Its B2B Push in India’s Enterprise and Industrial Markets
  • Heart and Lung Transplant Recipients Share Stories of a New Life at KIMS Patient Meet in Indore
  • Rahul Gupta: 10 Years of Selfless Service, Compassion and Humanity
  • Vijay Arora Announces Sataack 50, a Professional Tennis-Ball Cricket League for Men and Women

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • NEHA GUPTA- A mission to Normalize Therapeutic learning / An effort to make therapeutic learning more commonplace Lifestyle
  • MedLink, An Online Healthcare Recruitment Portal, Connecting Medical Professionals To Medical Recruiters Across the Country Business
  • Auric Metal and PVD Solution Expands across Asia with its Largest PVD Coating Machine Chamber Business
  • Driving Much Less Than Last Year? What to Review at Car Insurance Renewal Finance
  • Chamkila, A Musical Journey with Nitish R. Kumar Entertainment
  • Rajnish Wellness Limited Receives an In-principle Approval from Eastern Railway for setting up of Business Centres at 500 plus railway stations Business
  • India GDP growth 7.8 Percent : Power Surge in Q3 National
  • CII hosts the 2nd Manufacturing Excellence Summit Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme